Protein chip for the parallel quantification of high and low abundant biomarkers for sepsis

Anal Biochem. 2011 Dec 1;419(1):46-52. doi: 10.1016/j.ab.2011.07.038. Epub 2011 Aug 6.

Abstract

We present herein a protein chip for diagnosis of sepsis that combines both a sandwich and a binding inhibition format in order to quantify high (CRP) and low abundant proteins (cytokines, PCT, neopterin) in parallel. Using the combined assay format the lowest detectable concentrations for CRP, IL-6, IL-8, IL-10, TNFα, PCT, and neopterin are 3 mg/L, 15 ng/L, 26 ng/L, 65 ng/L, 40 ng/L, 78 ng/L, and 0.46 μg/L. Four different combined assay formats are tested, using separate or joint incubation steps of analytes and detection antibodies. Yet, low limit of detection (LOD) and short processing time are contradictory: while the combined assay performed in a multistep protocol is extremely sensitive (e.g., the LOD for IL-6 is 15 ng/L), but more time-consuming (4 h), the all-in-one protocol takes only 2.5 h, but suffers from lower sensitivity compared with the multistep protocol (e.g., the LOD for IL-6 is up to 40 times enhanced). Reproducibility is good in both cases (CV 5-20%).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis
  • C-Reactive Protein / analysis*
  • Calcitonin / analysis
  • Cytokines / analysis
  • Fluorescence
  • Humans
  • Immunoassay / methods*
  • Limit of Detection
  • Neopterin / analysis
  • Protein Array Analysis / methods*
  • Protein Precursors / analysis
  • Reagent Kits, Diagnostic
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Sepsis / diagnosis*
  • Streptavidin / chemistry

Substances

  • Biomarkers
  • Cytokines
  • Protein Precursors
  • Reagent Kits, Diagnostic
  • Neopterin
  • Calcitonin
  • C-Reactive Protein
  • Streptavidin